Docetaxel ụlọ ọrụ akụrụngwa

Ụlọ ọrụ akụrụngwa Docetaxel egosipụtara onyogho

Nkọwa dị mkpirikpi:

Docetaxel bụ ọgwụ kemịkalụ nke a na-eji agwọ ọrịa cancer dị iche iche. Ọrụ bụ isi bụ igbochi uto na mgbasa nke ọrịa cancer site na itinye aka na usoro Mitosis nke mkpụrụ ndụ tumo. Nke a nwere ike ime ka chromosomes nke mkpụrụ ndụ tumor ghara ikewapụ ma na-agagharị n'ụzọ ziri ezi, n'ikpeazụ na-eduga na ọnwụ cell tumor.

Zitere anyị email

Nkọwa ngwaahịa

Mkpado ngwaahịa

Ozi ngwaahịa

Aha:Docetaxel

Nọmba CAS:114977-28-5

Nkọwapụta:99%

Hande mmepụta ike

Usoro mmepụta:Ụbọchị 7.

Ike mmepụta Hande:e nwere ngwaahịa ngwaahịa, e nwere usoro, na uka mmepụta ga-ekwe omume.

Ọrụ nke docetaxel

Enwere ike iji Docetaxel na-agwọ ọrịa cancer ara, ọrịa cancer ovarian, cancer akpa ume, ọrịa afọ afọ, ọrịa cancer colorectal na ọrịa cancer ndị ọzọ. ibelata mmeghachi omume mkpasu iwe, na-akwalite nkwalite cell T cell na ịba ụba, ma si otú a na-eme ka ọrụ nchebe nke ahụ dịkwuo mma.

Ụlọ ọrụ Hande

Yunnan hande Biotechnology Co., Ltd., tọrọ ntọala na August 1993, bụ ụlọ ọrụ teknụzụ dị elu nke ọkachamara na nyocha na mmepe biotechnology.Mgbe ọtụtụ afọ nke mmepe gasịrị, hande eguzobewo usoro dị mma zuru oke, na-achịkwa àgwà ngwaahịa dịka ụkpụrụ dị elu si dị, ma mee ka uru mmepụta nke mmepụta ihe dị elu.Ngwaahịa ya agafeela asambodo nke iwu na ụkpụrụ mba dị iche iche, wee bụrụ onye nrụpụta akụrụngwa akụrụngwa nke na-eme onye ọ bụla nwee ahụ iru ala.